Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index
Climacteric. 2024 Oct 30:1-7. doi: 10.1080/13697137.2024.2418497. Online ahead of print. ABSTRACT OBJECTIVE: Oral, low-dose and ultra-low-dose continuous combined 17β-estradiol (E) plus dydrogesterone (D) reduce vasomotor …